Quick Answer
Regen BioPharma Inc reported Net Income of -$1.27 million for fiscal year 2025.
Regen BioPharma Inc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$1.27M | -90.7% |
| 2024 | -$668.3K | -157.8% |
| 2023 | $1.16M | -52.7% |
| 2022 | $2.44M | +136.1% |
| 2021 | -$6.77M | -298.1% |
| 2020 | $3.41M | +230.2% |
| 2019 | -$2.62M | +44.4% |
| 2018 | -$4.72M | +19.2% |
| 2017 | -$5.84M | +24.7% |
| 2016 | -$7.75M | +30.8% |
| 2015 | -$11.20M | -1380.1% |
| 2014 | -$756.4K | -113.0% |
| 2013 | -$355.0K | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | -$967.9K | -87.8% | -478.5% |
| June 30, 2025 | -$167.3K | -28.6% | -764.4% |
| March 31, 2025 | -$19.4K | +84.2% | +96.2% |
| December 31, 2024 | -$515.4K | -255.6% | -296.1% |
| June 30, 2024 | -$130.1K | -31.1% | -6.3% |
| March 31, 2024 | -$122.5K | -122.7% | +15.5% |
| December 31, 2023 | -$144.9K | -108.9% | -46.1% |
| June 30, 2023 | -$99.2K | -100.1% | -80.5% |
- Regen BioPharma Inc showed a decrease of -90.7% in Net Income compared to the prior fiscal year.
- Over the 2013–2025 period, Regen BioPharma Inc’s net income has declined by 259.0% (from -$355.0 thousand to -$1.27 million).
- The most recent figure is from Regen BioPharma Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: